Homocysteine and retinal emboli: The Blue Mountains Eye Study

被引:20
作者
Chua, Brian
Kifley, Annette
Wong, Tien Y.
Mitchell, Paul
机构
[1] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Westmead, NSW 2145, Australia
[2] Univ Melbourne, Dept Ophthalmol, Ctr Eye Res Australia, Melbourne, Vic, Australia
[3] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 117548, Singapore
关键词
D O I
10.1016/j.ajo.2006.03.039
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To examine the association between serum homocysteine and retinal emboli in a general older population. DESIGN: Cross-sectional population-based study. METHODS: Homocysteine level was determined from fast, ing venous blood collection at the second Blue Mountains Eye Study (BMES) (n = 3509, age :49 years, 1997 to 2000). Retinal emboli were graded from retinal photographs. Using logistic regression, we analyzed associations between serum homocysteine and retinal emboli adjusting for age, gender, hypertension, body mass index, and lipid levels. RESULTS: After multivariable adjustment, serum homo, cysteine was associated with presence of retinal emboli (odds ratio (OR) 1.2; 95% confidence interval (CI), 1.0 to 1.6 per standard deviation [4.8 mu mol/l] increase in serum homocysteine). CONCLUSION: Elevated serum homocysteine is weakly associated with increased odds of retinal emboli in this older population-based study.
引用
收藏
页码:322 / 324
页数:3
相关论文
共 7 条
[1]   Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease [J].
Austin, RC ;
Lentz, SR ;
Werstuck, GH .
CELL DEATH AND DIFFERENTIATION, 2004, 11 (Suppl 1) :S56-S64
[2]   Meta-analysis of plasma homocysteine, serum folate, serum vitamin B12, and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease [J].
Cahill, MT ;
Stinnett, SS ;
Fekrat, S .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (06) :1136-1150
[3]   Plasma homocysteine as a risk factor for vascular disease - The European concerted action project [J].
Graham, IM ;
Daly, LE ;
Refsum, HM ;
Robinson, K ;
Brattstrom, LE ;
Ueland, PM ;
PalmaReis, RJ ;
Boers, GHJ ;
Sheahan, RG ;
Israelsson, B ;
Uiterwaal, CS ;
Meleady, R ;
McMaster, D ;
Verhoef, P ;
Witteman, J ;
Rubba, P ;
Bellet, H ;
Wautrecht, JC ;
deValk, HW ;
Luis, ACS ;
ParrotRoulaud, FM ;
Tan, KS ;
Higgins, I ;
Garcon, D ;
Medrano, MJ ;
Candito, M ;
Evans, AE ;
Andria, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22) :1775-1781
[4]   Prevalence of asymptomatic retinal emboli in an Australian urban community [J].
Mitchell, P ;
Wang, JJ ;
Li, WN ;
Leeder, SR ;
Smith, W .
STROKE, 1997, 28 (01) :63-66
[5]   Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death - The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial [J].
Toole, JF ;
Malinow, MR ;
Chambless, LE ;
Spence, JD ;
Pettigrew, LC ;
Howard, VJ ;
Sides, EG ;
Wang, CH ;
Stampfer, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (05) :565-575
[6]   The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion [J].
Weger, M ;
Stanger, O ;
Deutschmann, H ;
Leitner, FJ ;
Renner, W ;
Schmut, O ;
Semmelrock, J ;
Haas, A .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 134 (01) :57-61
[7]  
Wong Tien Yin, 2002, Curr Opin Ophthalmol, V13, P142, DOI 10.1097/00055735-200206000-00002